Table 6.

Histologic data for the discovery set for protein array analysis

Non-CAICAIP Value
Histology at implantation (n=10)
 IF/TA grade >00/101/101.00
 arteriolar hyalinosis (present/absent)1/101/101.00
 intimal vascular thickening (present/absent)1/100/101.00
 glomerulosclerosis (present/absent)1/102/101.00
 Remuzzi score0.2±0.42 (0; 0–1)0.8±0.92 (0.5; 0–2)0.08
Histology at 6 months (n=10)
 tubulitis score >00/100/101.00
 interstitial inflammation score >00/101/101.00
 vasculitis score >00/100/101.00
 IF/TA grade >10/102/100.47
 arteriolar hyalinosis (present/absent)0/100/101.00
 intimal vascular thickening (present/absent)1/104/100.30
 glomerulosclerosis (present/absent)0/102/100.47
 CADI score0.6±0.70 (10.5;0–2)3.17±1.65 (3.5; 1–6)<0.0001
Histology at 24 months (n=10)
 tubulitis score >00/100/101.00
 interstitial inflammation score >00/100/101.00
 vasculitis score >00/100/101.00
 IF/TA grade >11/109/100.001
 arteriolar hyalinosis (present/absent)0/101/101.00
 intimal vascular thickening (present/absent)3/105/100.65
 glomerulosclerosis (present/absent)0/106/100.02
 CADI score1.6±1.6 (1.5; 0–5)7.1±1.5 (7;4–9)<0.0001
 CADI score slope in first 2 years0.7±0.9 (0.6; −0.3 to 2.5)2.9±0.6 (3.1; 1.9–3.8)<0.0001
Schwartz GFR
 at 6 months99.2±29.5 (93.6; 52–154)117.0±30.5 (102.9; 69.12–164.8)0.42
 at 24 months93.9±30.2 (98.6; 62–121)110.3±19.5 (100.1; 97.15–144)0.38
Absolute GFR
 at 6 months73.7±21.9 (70.6; 41–109)66.0±13.7 (67.2; 39–81)0.36
 at 24 months78.3±49.1 (102; 22–111)71.7±29.9 (87.8; 34–101)0.82